...
search icon
omga-img

Omega Therapeutics Inc, Common Stock

OMGA

NASDAQ

$0.154

-$0.03

(-15.91%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.30M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.64
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.1 L
$4.46 H
$0.154

About Omega Therapeutics Inc, Common Stock

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameOMGASectorS&P500
1-Week Return-30.16%0.54%0.54%
1-Month Return-69.2%3.28%1.66%
3-Month Return-80.51%3.01%3.83%
6-Month Return-90%-4.69%9.77%
1-Year Return-96.04%1.41%23.47%
3-Year Return-98.62%15.72%42.73%
5-Year Return-99.04%42.38%82.01%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--144.00K2.07M3.09M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":4.65,"profit":true},{"date":"2022-12-31","value":67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue794.00K1.15M1.39M5.19M65.87M[{"date":"2019-12-31","value":1.21,"profit":true},{"date":"2020-12-31","value":1.74,"profit":true},{"date":"2021-12-31","value":2.11,"profit":true},{"date":"2022-12-31","value":7.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(794.00K)(1.15M)(1.24M)2.07M(62.77M)[{"date":"2019-12-31","value":-38.3,"profit":false},{"date":"2020-12-31","value":-55.28,"profit":false},{"date":"2021-12-31","value":-59.96,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3028.22,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(863.19%)100.00%(2028.93%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":-863.19,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2028.93,"profit":false}]
Operating Expenses17.34M28.64M66.18M104.84M103.36M[{"date":"2019-12-31","value":16.54,"profit":true},{"date":"2020-12-31","value":27.32,"profit":true},{"date":"2021-12-31","value":63.12,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.58,"profit":true}]
Operating Income(17.34M)(28.64M)(66.03M)(102.77M)(100.26M)[{"date":"2019-12-31","value":-1733900000,"profit":false},{"date":"2020-12-31","value":-2864500000,"profit":false},{"date":"2021-12-31","value":-6603200000,"profit":false},{"date":"2022-12-31","value":-10276600000,"profit":false},{"date":"2023-12-31","value":-10026100000,"profit":false}]
Total Non-Operating Income/Expense(1.20M)(1.58M)(3.16M)287.00K5.40M[{"date":"2019-12-31","value":-22.22,"profit":false},{"date":"2020-12-31","value":-29.22,"profit":false},{"date":"2021-12-31","value":-58.44,"profit":false},{"date":"2022-12-31","value":5.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(17.95M)(29.45M)(68.28M)(102.70M)(97.43M)[{"date":"2019-12-31","value":-1794500000,"profit":false},{"date":"2020-12-31","value":-2944700000,"profit":false},{"date":"2021-12-31","value":-6828000000,"profit":false},{"date":"2022-12-31","value":-10270100000,"profit":false},{"date":"2023-12-31","value":-9742800000,"profit":false}]
Income Taxes584.00K752.00K882.00K(65.00K)6.60M[{"date":"2019-12-31","value":8.84,"profit":true},{"date":"2020-12-31","value":11.39,"profit":true},{"date":"2021-12-31","value":13.36,"profit":true},{"date":"2022-12-31","value":-0.98,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(18.53M)(30.20M)(69.16M)(102.64M)(104.03M)[{"date":"2019-12-31","value":-1852900000,"profit":false},{"date":"2020-12-31","value":-3019900000,"profit":false},{"date":"2021-12-31","value":-6916200000,"profit":false},{"date":"2022-12-31","value":-10263600000,"profit":false},{"date":"2023-12-31","value":-10403110500,"profit":false}]
Income From Continuous Operations(17.95M)(29.45M)(68.28M)(102.70M)(108.04M)[{"date":"2019-12-31","value":-1794500000,"profit":false},{"date":"2020-12-31","value":-2944700000,"profit":false},{"date":"2021-12-31","value":-6828000000,"profit":false},{"date":"2022-12-31","value":-10270100000,"profit":false},{"date":"2023-12-31","value":-10804000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(18.53M)(30.20M)(69.16M)(102.64M)(97.43M)[{"date":"2019-12-31","value":-1852900000,"profit":false},{"date":"2020-12-31","value":-3019900000,"profit":false},{"date":"2021-12-31","value":-6916200000,"profit":false},{"date":"2022-12-31","value":-10263600000,"profit":false},{"date":"2023-12-31","value":-9742800000,"profit":false}]
EPS (Diluted)(0.37)(0.79)(7.37)(2.14)(1.81)[{"date":"2019-12-31","value":-37.23,"profit":false},{"date":"2020-12-31","value":-79.4,"profit":false},{"date":"2021-12-31","value":-737,"profit":false},{"date":"2022-12-31","value":-214,"profit":false},{"date":"2023-12-31","value":-181,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OMGA
Cash Ratio 1.26
Current Ratio 1.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OMGA
ROA (LTM) -25.02%
ROE (LTM) -166.90%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OMGA
Debt Ratio Lower is generally better. Negative is bad. 0.92
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.08

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OMGA
Trailing PE NM
Forward PE NM
P/S (TTM) 1.29
P/B 1.01
Price/FCF NM
EV/R 13.52
EV/Ebitda NM

FAQs

What is Omega Therapeutics Inc share price today?

Omega Therapeutics Inc (OMGA) share price today is $0.154

Can Indians buy Omega Therapeutics Inc shares?

Yes, Indians can buy shares of Omega Therapeutics Inc (OMGA) on Vested. To buy Omega Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OMGA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Omega Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Omega Therapeutics Inc (OMGA) via the Vested app. You can start investing in Omega Therapeutics Inc (OMGA) with a minimum investment of $1.

How to invest in Omega Therapeutics Inc shares from India?

You can invest in shares of Omega Therapeutics Inc (OMGA) via Vested in three simple steps:

  • Click on Sign Up or Invest in OMGA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Omega Therapeutics Inc shares
What is Omega Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Omega Therapeutics Inc (OMGA) is $4.46. The 52-week low price of Omega Therapeutics Inc (OMGA) is $0.1.

What is Omega Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Omega Therapeutics Inc (OMGA) is 1.01

What is the Market Cap of Omega Therapeutics Inc?

The market capitalization of Omega Therapeutics Inc (OMGA) is $8.53M

What is Omega Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Omega Therapeutics Inc is OMGA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top